没有对HPV疫苗的犹
Douglas Sipp1, Ian H Frazer2, John E J Rasko3
1RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe, Japan; Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan; Keio Global Research Institute, 2 Chome-15-45 Mita, Minato-ku, Tokyo, Japan; RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Building, 15th floor, 1-4-1 Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan.
Cell
|March 10, 2018
概括
人类乳头瘤病毒 (HPV) 疫苗是安全的,可以预防癌症,但全球吸收率较低会阻碍人口免疫力. 需要改变政策, 以提高全球HPV疫苗接种覆盖率并挽救生命.
科学领域:
- 癌症学
- 疫苗学
- 公共卫生
背景情况:
- 人类乳头瘤病毒 (HPV) 疫苗的安全性和抗癌益处已得到充分证实.
- 尽管有压倒性的证据,全球HPV疫苗接种仍然不足以实现群体免疫.
研究的目的:
- 审查可以提高全球HPV疫苗覆盖率的政策措施.
- 确定提高全球HPV疫苗接种率的策略,以最大限度地预防癌症.
主要方法:
- 本研究综合了有关HPV疫苗有效性和安全性的现有证据.
- 它分析了导致全球疫苗接种差异的因素.
- 政策建议源于对成功的公共卫生干预措施的审查.
主要成果:
- 在不同国家,HPV疫苗覆盖率存在显著差异.
- 目前的吸收水平低于有效预防癌症的门.
- 具体的政策干预可以明显提高疫苗接种率.
结论:
- 实施有针对性的政策措施对于改善全球HPV疫苗覆盖率至关重要.
- 增加疫苗接种率将大大减少与HPV相关的癌症.
- 全球合作对于确保HPV疫苗的公平获取和使用至关重要.
相关概念视频
01:51Vaccinations
51.9K
Overview
51.9K
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K